Literature DB >> 19931348

Regulated expression of endothelial lipase in atherosclerosis.

Xiaoqian Wu1, Heqing Huang, Futian Tang, Kang Le, Suowen Xu, Peiqing Liu.   

Abstract

Endothelial lipase (EL) is a major determinant of HDL metabolism and associated with the development of atherosclerosis, however the regulated expression of EL in atherosclerosis is unclear. In this study, we investigated EL expression in rat atherosclerosis and explored the potential mechanisms regulating EL expression by employing LPS on Raw264.7 cells in vitro. Rat atherosclerosis model was established fed on high-cholesterol diet (HCD) combined with vitamin D(2) (VD). Western blotting and immunochemistry staining revealed that EL expression was increased in the aorta, especially the atherosclerotic lesions in HCD rats. LPS increased EL expression in a time and dose dependent manner in Raw264.7 cells and NFkappaB inhibitor, PDTC attenuated the effects of LPS on EL. EMSA revealed that LPS stimulated NFkappaB binding to EL promoter. In summary, EL was upregulated in rat atherosclerosis and LPS stimulates EL expression in vitro through NFkappaB activation. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931348     DOI: 10.1016/j.mce.2009.11.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  The role of HDL in innate immunity.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-10-13       Impact factor: 5.922

2.  Effect of the Kv1.3 voltage-gated potassium channel blocker PAP-1 on the initiation and progress of atherosclerosis in a rat model.

Authors:  Xiaofen Wu; Rende Xu; Ming Cao; Lei Ruan; Xingfen Wang; Cuntai Zhang
Journal:  Heart Vessels       Date:  2014-01-19       Impact factor: 2.037

3.  Association of endothelial lipase genetic polymorphism with lacunar infarction in a Chinese population.

Authors:  Jian Wang; Bo Zheng; Qing-Song Wang; Jun Wang; Sai-Yu Cheng; Jie Li
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Endothelial lipase is localized to follicular epithelial cells in the thyroid gland and is moderately expressed in adipocytes.

Authors:  Margery A Connelly; Michael R D'Andrea; Jenson Qi; Keli C Dzordzorme; Bruce P Damiano
Journal:  J Histochem Cytochem       Date:  2012-06-26       Impact factor: 2.479

5.  Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ.

Authors:  Un Ju Jung; Claudia Torrejon; Chuchun L Chang; Hiroko Hamai; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-04       Impact factor: 8.311

6.  Inhibition of endothelial lipase activity by sphingomyelin in the lipoproteins.

Authors:  Peng Yang; Natalia A Belikova; Jeff Billheimer; Daniel J Rader; John S Hill; Papasani V Subbaiah
Journal:  Lipids       Date:  2014-08-29       Impact factor: 1.880

7.  LIPG endothelial lipase and breast cancer risk by subtypes.

Authors:  Manuela Gago-Dominguez; Carmen M Redondo; Manuel Calaza; Marcos Matabuena; Maria A Bermudez; Roman Perez-Fernandez; María Torres-Español; Ángel Carracedo; J Esteban Castelao
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

8.  The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer.

Authors:  Xueyan Dong; Guoqing Wang; Guoqing Zhang; Zhaohui Ni; Jian Suo; Juan Cui; Ai Cui; Qing Yang; Ying Xu; Fan Li
Journal:  Diagn Pathol       Date:  2013-03-19       Impact factor: 2.644

9.  Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis.

Authors:  Yanni Xu; Suowen Xu; Peng Liu; Marina Koroleva; Shuya Zhang; Shuyi Si; Zheng Gen Jin
Journal:  J Am Heart Assoc       Date:  2017-11-30       Impact factor: 5.501

Review 10.  Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed.

Authors:  Jian Fang; Yongjun Zhang
Journal:  Front Pharmacol       Date:  2017-10-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.